New company co-founded by Rice faculty member aims to move beyond symptom management in preeclampsia
Emvena emerges from stealth with investment from the PxB Fund HOUSTON, Nov. 4, 2026 /PRNewswire/ -- Emvena Therapeutics, Inc., a biotechnology company co-founded by Rice University faculty member Kelsey Swingle announces its launch to develop a treatment for preeclampsia, a serious...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 145 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.